MetaCap

NervGen Pharma (NGEN) News

NASDAQ: NGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.85-0.075 (-3.91%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NGEN news summary

We found 4 recent headlines mentioning NervGen Pharma (NGEN): 2 in the past week and 3 in the past 30 days, most often from GlobeNewswire. For price context, NGEN is down 3.91% at $1.85. The most recent story, "NervGen Appoints Neuroscience Drug Development Leader Sam Jackson, MD, MBA, as Chief Medical Officer", was published by GlobeNewswire on Nov 18, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest NervGen Pharma headlines

Compare NGEN